199 related articles for article (PubMed ID: 6311491)
1. Pseudomonas aeruginosa and Acinetobacter calcoaceticus: in vitro susceptibility of 150 clinical isolates to five beta-lactam antibiotics and tobramycin.
Dibb WL; Asphaug Kjellevold V; Digranes A
Chemotherapy; 1983; 29(5):332-6. PubMed ID: 6311491
[TBL] [Abstract][Full Text] [Related]
2. N-formimidoyl thienamycin: in vitro comparison with cefoxitin and tobramycin against clinical, bacterial isolates.
Digranes A; Dibb WL; Benonisen E
Acta Pathol Microbiol Immunol Scand B; 1983 Apr; 91(2):141-4. PubMed ID: 6603093
[TBL] [Abstract][Full Text] [Related]
3. Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
Prince AS; Neu HC
Antimicrob Agents Chemother; 1981 Oct; 20(4):545-6. PubMed ID: 6282199
[TBL] [Abstract][Full Text] [Related]
4. Effects of inoculum size on the activity of carboxy- and ureido-penicillins and effects of combinations of ureido-penicillins with aminoglycosides against resistant Pseudomonas aeruginosa.
Watanakunakorn C
J Antimicrob Chemother; 1986 Jan; 17(1):91-5. PubMed ID: 3081474
[TBL] [Abstract][Full Text] [Related]
5. Cefoperazone against carbenicillin-resistant isolates of Pseudomonas aeruginosa: comparison with other newer cephalosporins and N-formimidoyl thienamycin.
Chau PY; Ling J; Ng WS
J Antimicrob Chemother; 1983 Oct; 12(4):337-45. PubMed ID: 6417100
[TBL] [Abstract][Full Text] [Related]
6. The in vitro activity of beta-lactam antibiotics against gentamicin and/or carbenicillin-resistant Pseudomonas aeruginosa strains.
Aisa ML; Omenaca M; Bergua C; Garcia-Moya JB
Infection; 1982; 10 Suppl 3():S244-8. PubMed ID: 6818157
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of beta-lactam resistance in British isolates of Pseudomonas aeruginosa.
Williams RJ; Livermore DM; Lindridge MA; Said AA; Williams JD
J Med Microbiol; 1984 Jun; 17(3):283-93. PubMed ID: 6327987
[TBL] [Abstract][Full Text] [Related]
8. [Comparative in vitro activity of 6 recent beta-lactams against hospital strains of Acinetobacter calcoaceticus: role of the monobactam SQ 26,776].
Joly-Guillou ML; Serieys C; Verin-Prevost C; Bergogne-Berezin E
Pathol Biol (Paris); 1983 May; 31(5):392-5. PubMed ID: 6353329
[TBL] [Abstract][Full Text] [Related]
9. Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
Perea EJ; Nogales MC; Aznar J; Martin E; Iglesias MC
J Antimicrob Chemother; 1980 Jul; 6(4):471-7. PubMed ID: 6253432
[No Abstract] [Full Text] [Related]
10. N-formimidoyl-thienamycin and norfloxacin against multiple-resistant Pseudomonas aeruginosa strains. Combined in vitro activity and comparison with 14 other antibiotics.
Martino P; Venditti M; Valente B; Brandimarte C; Serra P
Drugs Exp Clin Res; 1985; 11(4):247-51. PubMed ID: 3939121
[TBL] [Abstract][Full Text] [Related]
11. In vitro comparison of N-formimidoyl thienamycin (MK0787) and Azlocillin with three aminoglycosides and ticarcillin against Pseudomonas aeruginosa.
Matzkowitz AJ; Baltch AL; Smith RP; Sutphen NT; Hammer MC; Conroy JV
Antimicrob Agents Chemother; 1982 Apr; 21(4):685-7. PubMed ID: 6805426
[TBL] [Abstract][Full Text] [Related]
12. Comparative antibacterial activities of new beta-lactam antibiotics against Pseudomonas aeruginosa.
Fernandes CJ; Stevens DA; Ackerman VP
Chemotherapy; 1985; 31(4):292-6. PubMed ID: 3928282
[TBL] [Abstract][Full Text] [Related]
13. [Development and current status of Pseudomonas aeruginosa sensitivity to antibiotics].
Duval J; Soussy CJ
Presse Med; 1984 Mar; 13(13):763-7. PubMed ID: 6231591
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa.
Venditti M; Brandimarte C; Santini C; Valente B; Martino P; Serra P
Chemioterapia; 1984 Aug; 3(4):258-61. PubMed ID: 6442625
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives.
Cullmann W; Opferkuch W; Stieglitz M; Werkmeister U
Antimicrob Agents Chemother; 1982 Aug; 22(2):302-7. PubMed ID: 6821459
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of 341 non-fermentative gram-negative bacteria to seven beta-lactam antibiotics.
Appelbaum PC; Tamim J; Stavitz J; Aber RC; Pankuch GA
Eur J Clin Microbiol; 1982 Jun; 1(3):159-65. PubMed ID: 7173181
[TBL] [Abstract][Full Text] [Related]
17. In-vitro activity of ciprofloxacin and other beta-lactam antibiotics against gentamicin- and carbenicillin-resistant isolates of Pseudomonas aeruginosa.
Sofianou DC; Douboyas JP
J Chemother; 1991 Feb; 3(1):3-5. PubMed ID: 1902252
[TBL] [Abstract][Full Text] [Related]
18. Synergy of azlocillin with aminoglycosides.
Chin NX; Neu HC
J Antimicrob Chemother; 1983 May; 11 Suppl B():33-8. PubMed ID: 6413482
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro activities of azlocillin-cefotaxime and azlocillin-tobramycin combinations against blood and multi-drug resistant bacterial isolates.
Fass RJ
Antimicrob Agents Chemother; 1982 Jul; 22(1):167-9. PubMed ID: 6289737
[TBL] [Abstract][Full Text] [Related]
20. [Effect of multiresistance on the minimal inhibitory concentration of N-formimidoyl thienamycin and 6 comparing substances against P. aeruginosa and 4 Enterobacteriaceae species].
Schröter G; Schrettenbrunner A; Strenzel I
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb; 253(4):531-43. PubMed ID: 6407236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
